Published: 11 September 2022
Author(s): T. Vieceli, J. Rello
Section: Review Article

Many obstacles in antimicrobial stewardship (AMS) are shared across high-income countries (HICs) and low and middle-income countries (LMICs). Some of the issues raised in a workshop by the American Thoracic Society on AMS in the Intensive Care Unit (ICU) [1] are universal and could be applied to many different settings: excessively larger-spectrum drugs are often prescribed due to the fear of not covering a specific pathogen with narrow-spectrum antibiotics while waiting on cultures; unnecessary therapy escalation often occurs when a new clinical event, such as fever or hypotension, manifests within hours of therapy initiation, at a time when treatment response did not had enough time to occur or when such events are due to other reasons.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness